TTF1 and non-small cell lung carcinoma: To contextualize our findings within the broader literature, we performed a systematic review and meta-analysis of studies investigating TTF-1 expression as a prognostic biomarker in advanced NSCLC patients receiving immunotherapy-based regimens.